-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
ReShape Lifesciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $32K, a 85.2% decline year-over-year.
- ReShape Lifesciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $281K, a 68.6% decline year-over-year.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $767K, a 63.2% decline from 2022.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.09M, a 82.9% decline from 2021.
- ReShape Lifesciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.2M, a 824% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)